glp-1 agonists for weight loss Medications: Everything You Need to Know Weight Loss and Maintenance Related

Conclusion and Future Directions With the recent increase in GLP-1 RA use, it is essential to explore and understand the impact of these medications on the performance of gastrointestinal procedures such as EGD and colonoscopy

Unlike injectable GLP-1 receptor agonists, which bypass the stomach, the oral formulation relies on an absorption enhancer to facilitate uptake in the gastrointestinal tract

Molecular physiology of reverse cholesterol transport

Current research on the interaction between allulose and GLP-1 is predominantly preclinical and small acute randomised crossover studies , with limited large-scale human trials specifically examining their combined effects

Concerns about thyroid cancer risk and the potential for sarcopenia or bone fragility in older patients further underscore the need for long-term surveillance (Nunn et al., 2024)